# Theriva Biologics, Inc.: Form DEF 14A, filed Mar 16, 2026

- Company: [Theriva Biologics, Inc.](/companies/tovx.md) (CIK 894158)
- Form: DEF 14A
- Filed: 2026-03-16
- Accepted by EDGAR: Mar 16, 2026, 17:32 ET
- Period: 2026-04-09
- Accession: 0001104659-26-028593
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/894158/000110465926028593/tm267779-2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/894158/000110465926028593/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/894158/000110465926028593/tm267779-2_def14a.htm

Filed Mar 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-028593. Last ingested by Listed: Nov 2, 2026, 16:32 ET. No prices; not investment advice.